Text size

UBS GWM to offer Asian HNWIs T. Rowe Price health strategy through exclusive deal

T. Rowe Price has announced an exclusive distribution partnership with UBS Global Wealth Management (GWM) through which the Swiss lender will offer the T. Rowe Price Health Sciences Equity Strategy to its private wealth clients in Hong Kong and Singapore. The strategy, which was incepted in 1995, is dedicated to investing in health sciences companies and has US$ 19.3 billion in…

To access this content, please click back to the home screen, then click “Menu” (bars in top left bars) and then “Login”.
To enquire for a free trial, please start here.
Need more help? Click here or email [email protected].

Have a confidential tip? Get in touch [email protected]